Trials / Conditions / Squamous Cell Carcinoma of Unknown Primary
Squamous Cell Carcinoma of Unknown Primary
4 registered clinical trials studyying Squamous Cell Carcinoma of Unknown Primary — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Nec NCT06868433 | Emory University | Phase 1 |
| Active Not Recruiting | Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcin NCT04862650 | Marcelo Bonomi | Phase 2 |
| Completed | Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck NCT03258554 | National Cancer Institute (NCI) | Phase 2 / Phase 3 |
| Active Not Recruiting | Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractor NCT02978625 | National Cancer Institute (NCI) | Phase 2 |